 , Agents Causing Muscle Toxicity , Alkaloids , Antimitotic Agents , Antineoplastic Agents , Antineoplastic Agents, Phytogenic , Antineoplastic and Immunomodulating Agents , BCRP/ABCG2 Substrates , BSEP/ABCB11 Substrates , BSEP/ABCB11 Substrates with a Narrow Therapeutic Index , Cardiotoxic antineoplastic agents , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A7 Substrates , Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Substrates , Heterocyclic Compounds, Fused-Ring , Immunosuppressive Agents , Indole Alkaloids , Indoles , Indolizidines , Indolizines , Mitosis Modulators , Narrow Therapeutic Index Drugs , Neurotoxic agents , OATP1B1/SLCO1B1 Inhibitors , OATP1B3 inhibitors , P-glycoprotein inducers , P-glycoprotein inhibitors , P-glycoprotein substrates , P-glycoprotein substrates with a Narrow Therapeutic Index , Secologanin Tryptamine Alkaloids , Tubulin Modulators , Vinca Alkaloids